Skip to content

Effects of Resistance Exercise Compared to Whole-body Electromyostimulation in Young Female Dentists.

Effects of a Single Bout of High Intensity, High Velocity Resistance Exercise Compared to Whole-body Electromyostimulation on Cardiometabolic Risk Factors and Markers of Bone Formation and -Resorption in Young Female Dentists.

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06813092
Acronym
FeDeBoMa
Enrollment
16
Registered
2025-02-06
Start date
2025-03-15
Completion date
2025-08-30
Last updated
2026-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiometabolic Conditions, Osteopenia

Keywords

biomarkers, bone metabolism, exercise, whole-body electromyostimulation, female dentists

Brief summary

Due to their high workload and unfavorable working position, young female dentists are particularly at risk of cardiometabolic diseases and an early reduction in bone mineral density (BMD). With focus on the latter issue, short bouts of resistance exercise with high strain magnitude and velocity are commonly considered to be a feasible option to prevent bone loss in the early years of young adulthood. In parallel, whole-body electromyostimulation (WB-EMS) a trainings technology able address all main muscle groups simultaneously, however with dedicated exercise intensity might be a time-effective, joint friendly and safe option to maintain BMD in people unable or unmotivated to exercise conventionally. In the present study, we aim to compare the effects of a single session of WB-EMS versus high intensity, high velocity resistance exercise on biomarkers of bone formation (Procollagen type 1 N propeptide, P1NP) and resorption (C-terminal telopeptide of type I collagen, CTX-I). We hypothesize that no clinically relevant different effects on P1NP and CTX-I were determined.

Interventions

20 min of WB-EMS (bipolar, 85 Hz, 350 µs, 6s impulse - 4s impulse break)

OTHERResistance exercise

High-intensity/high velocity multiple set resistance exercise

Sponsors

University of Erlangen-Nürnberg Medical School
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
OTHER
Masking
SINGLE (Outcomes Assessor)

Masking description

Outcome assessor were not aware of the group status and were not allowed to ask correspondingly

Intervention model description

Randomized two-arm cross-over design

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 30 Years
Healthy volunteers
No

Inclusion criteria

* female dental students (\>3rd semester) or licensed dentists * no competitive sports background for \>2 years * normal body mass (BMI\>18,5 and \<25 kg/m2)

Exclusion criteria

* more than one resistance exercise session per week (last 12 month) * whole-body electromyostimulation during the last 12 month * amenorrhea, oligomenorrhea

Design outcomes

Primary

MeasureTime frameDescription
Changes for C-terminal telopeptide of type I collagen from pre- to 15 min post-exerciseImmediately pre-exercise to 15 min post exercise of a single exercise sessionChanges for C-terminal telopeptide of type I collagen (CTX-I) serum levels from pre- to 15 min post-exercise as determined by blood samples

Secondary

MeasureTime frameDescription
Changes for Procollagen type 1 N propeptide from pre- to 15 min post-exerciseImmediately pre-exercise to 15 min post exercise of a single exercise sessionChanges for Procollagen type 1 N propeptide (P1NP) serum levels from pre- to 15 min post-exercise as determined by blood samples
Changes for resting glucose from pre- to 15 min post-exerciseImmediately pr to 15 min post-exercise of a single exercise sessionChanges for resting glucose serum levels from pre- to 15 min post-exercise as determined by blood samples
Changes for hemoglobin A1c from pre- to 15 min post-exerciseImmediately pre- to 15 min post-exercise of a single exercise sessionChanges for hemoglobin A1c (HBA1C) serum levels from pre- to 15 min post-exercise as determined by blood samples

Countries

Germany

Contacts

PRINCIPAL_INVESTIGATORWolfgang Kemmler, PhD

University Hospital Erlangen, Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026